MYCN and precursor B-cell acute lymphoblastic leukemia: This finding suggests that MYCN plays a proto‐oncogenic role and indicates that MYCN is a potential component of adult B‐ALL pathogenesis and may therefore be a viable candidate for targeted therapy.